What's New on NCI’s Websites?
December 22, 2015, by NCI Staff
NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.
Email Subscription Service for NCI Information
NCI has implemented a new email subscription service to make it easier to learn about new resources and information from NCI.
Thyroid Cancer Statistics Video
Thyroid cancer is the eighth most common cancer in the United States. Did you know that this cancer is highly treatable and usually curable? Learn more in the Thyroid Cancer Statistics video, part of NCI’s Surveillance Research Program’s Did You Know? video series. Visit the SEER website for more interactive tools and fact sheets on cancer statistics.
New Research Updates and Results from Clinical Trials
Use of estrogen-alone hormone replacement therapy may improve overall survival for women with epithelial ovarian cancer, according to results from a large clinical trial.
A recent research update on Shared Decision Making to Improve Cancer Screening Choices describes efforts to help patients make informed decisions about cancer screening that reflect their values and preferences.
Some cancer treatments may damage the heart. In this new research update, Treating Cancer without Harming the Heart, learn how researchers from the fields of oncology and cardiology are working to find ways to prevent, manage, and possibly even reverse these side effects.
Donating Your Tissue for Research
This short video discusses tissue donation as part of cancer research. Hear from Sue Scott, a cancer survivor, and her physician, Christian Hinrichs, M.D., of NCI’s Center for Cancer Research, as they describe what tissue donation has meant to them and why they are such passionate advocates for donating tissue for cancer research.
For more information, see our comprehensive booklet Providing Your Tissue for Research: What You Need to Know.
Driving Discovery Video
Progress against cancer depends on many types of research—including basic, translational, and clinical—across different research areas, from studying the biology of cancer cells to analyses of large populations. The new Driving Discovery video explains how NCI, in its role as coordinator of the National Cancer Program, provides the resources and support needed to perform much of this research.
New Drug Information Summaries
Stay up to date on the latest approvals of new therapies by the Food and Drug Administration with these new Drug Information Summaries:
- Daratumumab (Darzalex™) for the treatment of multiple myeloma in patients who have already received at least three other types of treatment
- Osimertinib (Tagrisso™) for the treatment of non-small cell lung cancer in patients whose tumors have a certain mutation and who have already been treated with a similar drug
- Talimogene laherparepvec (Imlygic™) for the treatment of melanoma in the skin and lymph nodes that cannot be removed by surgery in patients with recurrent disease
- Trabectedin (Yondelis®) for the treatment of certain types of soft tissue sarcoma that cannot be removed by surgery or that have spread to other parts of the body
Know Your Chances
The recently launched Know Your Chances website provides a snapshot of the risk of dying from a variety of cancers and other diseases over specific time frames. Because age, sex, and race are so important in determining this risk, the site helps users account for these factors.
New Images Added to NCI Visuals Online
NCI Visuals Online provides a range of photographs and illustrations that may help medical and public health communicators convey meaning, describe concepts, and tell stories. Since November, 50 new images have been added to the collection, which now includes more than 3,000 images.
NCI's Developmental Therapeutics Clinic
Learn about NCI's Developmental Therapeutics Clinic (DTC) on its new website. The DTC, part of the Division of Cancer Treatment and Diagnosis (DCTD), conducts early-phase clinical trials of novel cancer treatment agents.
Google Hangout on Lung Cancer Precision Medicine Clinical Trials
During Lung Cancer Awareness month, NCI’s Shakun Malik, M.D., and Roy Herbst, M.D., from the Yale School of Medicine, talked about the changing landscape of lung cancer treatment and precision medicine lung cancer clinical trials in this Google Hangout, which was moderated by lung cancer research advocate Janet Freeman-Dailey.
Learn about upcoming social media events and view past events on the NCI Social Media Events page.
New Updates from the Center for Cancer Genomics
NCI’s Center for Cancer Genomics has published several updates about its research activities on its Insights & Innovations blog, including new posts on The Cancer Genome Atlas and Cancer Informatics and an interview with Matthew Meyerson, M.D., Ph.D., from Dana-Farber Cancer Institute and Harvard Medical School.
Fall 2015 Issue of DCEG Linkage Available
NCI’s Division of Cancer Epidemiology and Genetics (DCEG) has published the Fall 2015 issue of DCEG Linkage. This issue of the research newsletter includes articles about new insights into genetic susceptibility to non-Hodgkin lymphoma, HPV vaccination and pregnancy outcomes, and scientific highlights of recent publications by DCEG researchers.